SPRED1 and neoplasm: This study establishes TTC36 as a pivotal tumor suppressor in hepatocellular carcinoma that orchestrates a previously unrecognized TTC36/YBX3/SPRED1 signaling axis which suppresses Ras/MAPK pathway to constrain tumor proliferation.